JP2023522134A5 - - Google Patents

Info

Publication number
JP2023522134A5
JP2023522134A5 JP2023505811A JP2023505811A JP2023522134A5 JP 2023522134 A5 JP2023522134 A5 JP 2023522134A5 JP 2023505811 A JP2023505811 A JP 2023505811A JP 2023505811 A JP2023505811 A JP 2023505811A JP 2023522134 A5 JP2023522134 A5 JP 2023522134A5
Authority
JP
Japan
Prior art keywords
item
pharmaceutically acceptable
items
stable
apomorphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023505811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/026904 external-priority patent/WO2021207737A2/en
Publication of JP2023522134A publication Critical patent/JP2023522134A/ja
Publication of JP2023522134A5 publication Critical patent/JP2023522134A5/ja
Pending legal-status Critical Current

Links

JP2023505811A 2020-04-10 2021-04-12 長時間作用型アポモルフィン製剤、およびその治療送達用のインジェクター Pending JP2023522134A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063008369P 2020-04-10 2020-04-10
US63/008,369 2020-04-10
PCT/US2021/026904 WO2021207737A2 (en) 2020-04-10 2021-04-12 Long-acting apomorphine formulations and injectors for therapeutic delivery of the same

Publications (2)

Publication Number Publication Date
JP2023522134A JP2023522134A (ja) 2023-05-26
JP2023522134A5 true JP2023522134A5 (https=) 2024-04-23

Family

ID=78023709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505811A Pending JP2023522134A (ja) 2020-04-10 2021-04-12 長時間作用型アポモルフィン製剤、およびその治療送達用のインジェクター

Country Status (5)

Country Link
US (1) US20230137010A1 (https=)
EP (1) EP4132475A4 (https=)
JP (1) JP2023522134A (https=)
CA (1) CA3179866A1 (https=)
WO (1) WO2021207737A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240315971A1 (en) * 2023-03-03 2024-09-26 Lotus Biopharma Inc. Microsphere formulations and methods of preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436950B1 (en) * 1998-08-14 2002-08-20 Nastech Pharmaceutical Company, Inc. Nasal delivery of apomorphine
JP2003052819A (ja) * 2001-08-10 2003-02-25 Seikagaku Kogyo Co Ltd 薬剤充填注射器包装物およびその滅菌または殺菌方法
PT1610791E (pt) * 2003-03-31 2011-05-23 Titan Pharmaceuticals Inc Dispositivo polim?rico implant?vel para liberta??o sustentada de agonista da dopamina
CN103827177B (zh) * 2011-07-22 2016-02-10 伊诺科雷技术有限公司 用于生物活性化合物的受控释放的生物可降解的、半结晶的、相分离的、热塑性多嵌段共聚物
JP2015510818A (ja) * 2012-03-20 2015-04-13 トラスティーズ オブ タフツ カレッジ 薬物送達のための絹リザーバー
WO2014165136A1 (en) * 2013-03-12 2014-10-09 Antares Pharma, Inc. Constant volume prefilled syringes and kits thereof

Similar Documents

Publication Publication Date Title
US20230091533A1 (en) Biodegradable drug delivery compositions
JP5951991B2 (ja) 医薬組成物
EP2866837B1 (en) Biodegradable drug delivery for hydrophobic compositions
EP3655038B1 (en) Pharmaceutical composition
CN101365423A (zh) 缓释小分子药物制剂
JP2023522134A5 (https=)
JP2023522987A5 (https=)
JP2024091835A (ja) 持続性ブピバカインマイクロスフェア製剤
US20230137010A1 (en) Long-acting apomorphine formulations and injectors for therapeutic delivery of the same
US20190117573A1 (en) Composition and method of preparation of risperidone extended release preparation
HK40104581A (zh) 包含他克莫司的药物制剂、其制备方法和用途
HK1248146A1 (en) Biodegradable drug delivery compositions
HK1208374B (en) Biodegradable drug delivery for hydrophobic compositions
HK1190925B (en) Biodegradable drug delivery compositions
HK1190925A (en) Biodegradable drug delivery compositions